Short-term safety of 2 mg intravitreal ziv-aflibercept
Retina Sep 30, 2017
Chhablani J, et al. - This study was formulated in order to determine the safety of single intravitreal 2 mg ziv-aflibercept (0.08 mL) injections, for the treatment of choroidal neovascular membranes (CNVM). The treatment with single intravitreal injections of 2 mg ziv-aflibercept (0.08 mL) was disclosed to be safe, through 1 month.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
